Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint Inhibitors.
Madeleine Di Frisco, Miguel F Sanmamed, José María Ferrández, Anna Vilalta, Miguel Sogbe, Marta García-Goñi, Ángela Martin-Palmero, Samantha Aso-González, Ernest Nadal, Jaime Signes-Costa, Valentina Gambardella, Víctor Seguí Manzaneque, Paloma Martin, Amelia Insa, José Franco
Published: 202510.1016/j.jtho.2025.10.007
Abstract
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) and emphysema are independent risk factors for lung cancer development and have been independently associated with longer overall survival (OS) in patients with NSCLC treated with immune chec…
Preview only. Read the full abstract at the source